Ennaid Therapeutics
From Zikv.in
Revision as of 22:07, 14 February 2016 by Cooleo (Talk | contribs) (Created page with "Ennaid Therapeutics is developing a proprietary platform technology of flavivirus fusion inhibitors that show significant inhibition against flavivirus infectivity, such as De...")
Ennaid Therapeutics is developing a proprietary platform technology of flavivirus fusion inhibitors that show significant inhibition against flavivirus infectivity, such as Dengue, et al. Their rapid development plan has the potential to safely and quickly bring a Zika virus therapeutic cure to market in record time. The company was founded in 2012.
Ennaid Therapeutics is based in Alpharetta, GA.
For years, Ennaid Therapeutics has been committed to developing cures for mosquito-borne diseases, including Dengue, Chikungunya and Zika viruses – and is now advancing its work on Zika to address the urgent global need.
| ||||||||